Related Experiment Video

Updated: Jul 29, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Mechanical circulatory assistance in paediatric patients with cardiac failure

A Khan1, A B Gazzaniga

  • 1Department of Cardiothoracic Surgery, University of California, Irvine Medical Center, Orange County 92668, USA.

Cardiovascular Surgery (London, England)
|February 1, 1996
PubMed

Insights

Mechanical circulatory support devices, including extracorporeal membrane oxygenation (ECMO), left ventricular assist devices (LVAD), and intraaortic balloon pumps (IABP), offer excellent outcomes for pediatric cardiac patients. These advanced treatments demonstrate a high survival rate and positive long-term results.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Extracorporeal membrane oxygenation (ECMO) was initially developed for respiratory failure.
  • Mechanical circulatory support devices have evolved for pediatric cardiac disease management.
  • Left ventricular assist devices (LVAD) and intraaortic balloon pumps (IABP) are used in pediatric heart failure.

Purpose of the Study:

  • To evaluate the efficacy of mechanical circulatory support devices in pediatric cardiac patients.
  • To document outcomes for infants and children treated with ECMO, LVAD, or IABP.
  • To assess the role of these devices in preoperative and postoperative cardiac care.

Main Methods:

  • Retrospective analysis of 15 pediatric patients treated with mechanical devices.
  • Inclusion of devices like ECMO, LVAD, and IABP, individually or in combination.
  • Focus on preoperative and postoperative application in congenital and acquired heart disease.

Main Results:

  • A 74% survival rate was observed in the patient cohort.
  • Long-term outcomes were excellent in the majority of cases.
  • Heparin-coated devices and strict heparin regulation facilitated safe transitions from cardiopulmonary bypass.

Conclusions:

  • Mechanical devices are crucial for managing pediatric cardiac disease.
  • These devices provide essential preoperative and postoperative support.
  • The use of advanced mechanical support improves survival and long-term outcomes in pediatric cardiac surgery.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

Related Concept Videos

Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...